Biora Therapeutics Inc expected to post a loss of 12  cents a share - Earnings Preview

Biora Therapeutics

09/08/2022 24:00

* Biora Therapeutics Inc  BIOR.OQ   BIOR.O  is expected
to show a
fall in quarterly revenue when it reports  results on August
15. 
    * ​Refinitiv's mean analyst estimate for Biora Therapeutics
Inc is
for a loss of 12 cents per share. For the same quarter last
year, the company reported a loss of 65 cents per share.
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Biora
Therapeutics Inc is $5​, above​ its last closing price of $0.81.
​​​

This summary was machine generated August 8 at 23:00 GMT.  All
figures in US dollars  unless otherwise stated